| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Medicine, Columbia University, New York, NY 10032
Optimal humoral responses depend on the activation of Ag-specific B cells, followed by their progression toward a fully differentiated phenotype. Acquisition of stage-appropriate patterns of gene expression is crucial to this differentiation program. However, the molecular mechanisms used by B cells to modulate gene expression as they complete their maturation program are poorly understood. IFN-regulatory factor 4 (IRF-4) plays a critical role in mature B cell function. Using the transcriptional regulation of the human B cell activation marker CD23 as a model system, we have previously demonstrated that IRF-4 is induced in response to B cell-activating stimuli and that it acts as a transactivator of CD23 gene expression. We have furthermore found that IRF-4 function can be blocked by B cell lymphomas 6 (BCL-6) protein, a Krüppel-type zinc finger repressor normally expressed in germinal center B cells. However, CD23 expression is known to be down-regulated in plasma cells despite high level expression of IRF-4 and the lack of BCL-6, suggesting that in plasma cells the IRF-4-mediated induction of CD23 is prevented by its interaction with a distinct repressor. In this set of studies, we demonstrate that IRF-4 interacts with B lymphocyte-induced maturation protein/positive regulatory domain I-binding factor 1 (Blimp1/PRD1-BF1), a Krüppel-type zinc finger protein whose expression correlates with terminal B cell differentiation. Functional studies indicate that Blimp1, like BCL-6, can block IRF-4-transactivating ability. These findings thus support a model whereby IRF-4 function is modulated in a stage-specific manner by its interaction with developmentally restricted sets of Krüppel-type zinc finger proteins.
This article has been cited by other articles:
|
|
 |
|
  J. M. Polo, W. Ci, J. D. Licht, and A. Melnick Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells Blood, August 1, 2008; 112(3): 644 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cattoretti, R. Shaknovich, P. M. Smith, H.-M. Jack, V. V. Murty, and B. Alobeid Stages of Germinal Center Transit Are Defined by B Cell Transcription Factor Coexpression and Relative Abundance J. Immunol., November 15, 2006; 177(10): 6930 - 6939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Corcoran, J. Hasbold, W. Dietrich, E. Hawkins, A. Kallies, S. L. Nutt, D. M. Tarlinton, P. Matthias, and P. D. Hodgkin Differential requirement for OBF-1 during antibody-secreting cell differentiation J. Exp. Med., May 2, 2005; 201(9): 1385 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Hoefnagel, R. Dijkman, K. Basso, P. M. Jansen, C. Hallermann, R. Willemze, C. P. Tensen, and M. H. Vermeer Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling Blood, May 1, 2005; 105(9): 3671 - 3678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. van der Stoep, E. Quinten, M. M. Rezende, and P. J. van den Elsen E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII) Blood, November 1, 2004; 104(9): 2849 - 2857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gyory, G. Fejer, N. Ghosh, E. Seto, and K. L. Wright Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines J. Immunol., March 15, 2003; 170(6): 3125 - 3133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Fanzo, C.-M. Hu, S. Y. Jang, and A. B. Pernis Regulation of Lymphocyte Apoptosis by Interferon Regulatory Factor 4 (IRF-4) J. Exp. Med., February 3, 2003; 197(3): 303 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-M. Hu, S. Y. Jang, J. C. Fanzo, and A. B. Pernis Modulation of T Cell Cytokine Production by Interferon Regulatory Factor-4 J. Biol. Chem., December 13, 2002; 277(51): 49238 - 49246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nagulapalli, A. Goheer, L. Pitt, L. P. McIntosh, and M. L. Atchison Mechanism of E47-Pip Interaction on DNA Resulting in Transcriptional Synergy and Activation of Immunoglobulin Germ Line Sterile Transcripts Mol. Cell. Biol., October 15, 2002; 22(20): 7337 - 7350. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
